Adolescents assigned female at birth account for a significant majority of minors receiving gender-affirming care, including top surgery, fueling debate about the influence of peer groups and social media reut.rs/3Gsmdm5 via Reuters Investigates

Demand for care among England’s trans teens is growing. So are obstacles to treatment reuters.com/investigates/s… with Chad Terhune Robin Respaut

Our latest story about why detransitioners are crucial to the science of gender care, with Chad Terhune Michelle Conlin reuters.com/investigates/s…

My baby's cancer may have returned and my insurance, Cigna Healthcare, is refusing to help cover a PET scan so we can find out if it has, and if needed, continue our work to save his life. No qualms about putting my child's life on the line for their bottom line. He is not even 2 years old

INSANE conditions on Mt Washington, NH. 120mph+ winds and -95°F wind chill. It is above the tropopause, meaning that these are stratospheric winds. Footage from the summit live stream 2:30-2:40pm. #nhwx

As African kids died, doctors fought for ban on toxic Indian syrup. A haunting special report by ⁦Reuters⁩ reuters.com/investigates/s…

This was farmland in the southern San Joaquin Valley (Kings County, south of Corcoran). #flooding It’s now more of an ocean

Announcing the winners for the 2023 #NIHCM Awards in Journalism and Research! bit.ly/2023NIHCMAwards #NIHCMAwardsJournalism #NIHCMAwardsResearch KFF Health News NPR CBS News Reuters News from Science Aftershockdoc Onyx Collective ABC News Hulu AEA Journals

Congratulations to Robin Respaut, Chad Terhune, Michelle Conlin and Jennifer Rigby of Reuters for winning @NIHCM's 2023 General Circulation Journalism Award for their excellent series, "Youth in Transition." Well deserved!

Nicholas England, a healthy 22-year-old from Virginia, shot himself in the head in 2017 shortly after starting to take an allergy medicine. His parents were blocked from suing drug companies by Supreme Court precedents reut.rs/3CMgi8v

Our latest: Merck’s best-selling asthma and allergy medicine, Singulair, has been linked for years to suicides and psychiatric problems, often in children. reuters.com/investigates/s… w/@FedcourtJunkie @kristinacooke Mike Spector and Ben Lesser

Are you an early career Indian photographer? Reuters has launched the Danish Siddiqui Photojournalism Internship in memory of our late colleague who continues to inspire us all. This year-long, paid internship, will be based in Delhi. Join our team: bit.ly/45MIu81

Our latest story describes the experiences of patients who took the new, popular weight-loss drugs and experienced suicidal thoughts. reut.rs/3ZznuiO with Chad Terhune

My latest story with colleague Robin Respaut. We dug into the FDA's adverse events database, filed public records requests and interviewed numerous doctors and patients about this potential safety issue #obesity #patientsafety reuters.com/business/healt…

How Novo Nordisk forged financial ties with leading obesity doctors with broad influence over how weight-loss drugs like Wegovy are used. Reuters investigates reut.rs/3T5uH92 by Chad Terhune Robin Respaut via Reuters Investigates

Some top obesity experts are promoting weight-loss drugs for tens of millions of Americans. Some of those same doctors also took large amounts of money from Novo Nordisk, the maker of Wegovy and Ozempic, Reuters found reut.rs/46UIkeR by Chad Terhune Robin Respaut

Novo Nordisk, maker of Wegovy and Ozempic, has spent millions of dollars on doctors and obesity experts who exert influence over how weight-loss drugs are dispensed and covered by insurance reut.rs/49YLAbH by Chad Terhune Robin Respaut via Reuters Investigates

As sales soar for Wegovy and Ozempic, there’s growing debate on how widely these powerful and expensive weight-loss medications should be prescribed and for how long reut.rs/3T1kJFS by Chad Terhune Robin Respaut via Reuters Investigates

Exclusive: US families begin to embrace weight-loss drugs for their children, data show. My latest w/ Robin Respaut #obesity #wegovy #pediatrics reuters.com/business/healt…

Our latest story examines new data showing the rise of adolescents taking Wegovy, GLP1s, for weight-loss. With Chad Terhune reuters.com/business/healt…